Skyhawk Therapeutics is a drug discovery and development company that aims to improve disease treatment with small molecules that correct RNA expression. Their founders are experts in small molecule therapeutics development for RNA-based disease, and their first drug candidates target cancers and neurological conditions. The company is located in Waltham, Massachusetts.